OLIGOMA Trial: SBRT Extends PFS in Oligometastatic Breast Cancer

oncodaily - The OLIGOMA trial presented at ESTRO 2026 brings new attention to one of the most debated questions in metastatic breast cancer: can treating limited metastatic sites with stereotactic body radiotherapy […]

AI Summary: A randomized trial shows stereotactic body radiotherapy (SBRT) targeting limited metastatic breast lesions prolongs progression‑free survival, offering longer disease control for selected patients with oligometastatic disease. Toxicity was manageable, suggesting SBRT could become a pragmatic, tissue‑sparing option to delay systemic therapy escalation.


ESTRO reaction: clinicians and advocates amplify SBRT findings

Olubukola Ayodele: The Recent OLIGOMA Trial Adds Important Data on Oligometastatic Breast Cancer

3 months / oncodaily

Melek Tugce Yilmaz: Real-World Evidence for SBRT in Oligometastatic Disease

3 months / oncodaily

Ssemata Benjamin: Amplifying Radiotherapy Voices at ESTRO2026

3 months / oncodaily


EXTEND and practice: metastasis-directed therapy, guidelines, and AI

Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context

3 months / esmo

Deep learning and radiomics models in patients with advanced non-small cell lung cancer treated with immunotherapy combined with stereotactic radiotherapy

3 months / nature

Karamvir Yadav: EXTEND Trial Shows Improved PFS in Oligometastatic Disease

3 months / oncodaily

Practical Radiation Oncology: SBRT for Non-Spine Bone Metastases Review – ASTRO

3 months / oncodaily


OLIGOMA: SBRT extends PFS in oligometastatic breast cancer

Targeted Radiotherapy Could Extend Control in Early Metastatic Breast Cancer

3 months / oncodaily

OLIGOMA Trial: SBRT Extends PFS in Oligometastatic Breast Cancer

3 months / oncodaily

Breast cancer that has begun to spread could be controlled for longer with targeted radiotherapy

3 months / medicalxpress


All Other Stories

Metastatic Breast Cancer: ESMO Clinical Practice Guideline

3 months / esmo

Chadi Nabhan: ASCO and Ryght AI Collaborate on Breast Cancer Clinical Trial Site Selection

3 months / oncodaily

Suhani: How to Evaluate Bone Metastasis in Breast Cancer Without Nuclear Medicine Access

3 months / oncodaily

Sushil Beriwal: Join for ISRS Symposium on Trigeminal Neuralgia, Prostate SBRT and SRS Applications

3 months / oncodaily

Balazs Halmos with Daniel Araujo: This Should Be the New Standard of Care for Bone-Metastatic Breast

3 months / oncodaily

George Kumar: Mapping TNBC at Single Cell Resolution

3 months / oncodaily

Marcin Kubeczko: Exciting ESTRO 2026 Highlights Powerful Advances in Breast Radiation Oncology

3 months / oncodaily

10 Must-Read Posts In Radiotherapy This Week

3 months / oncodaily

Sushil Beriwal: Optimizing Hyperarc Planning to Improve Quality Metrics and Care in Linac Based SRS

3 months / oncodaily

Empowering the Next Generation in Radiation Oncology – ESTRO

3 months / oncodaily

Tinatin Alaverdashvili: OncoSpaceX at the ESTRO Congress in Stockholm

3 months / oncodaily

Omar Abdihamid: African Perspectives in Global Radiation Oncology Discussions at ESTRO

3 months / oncodaily

ESTRO: Select breast cancer patients may be able to omit surgery following ablative radiation

3 months / medicalxpress

Back to Top / Mon, May 18, 2026, 12:21 am / permalink 23933 / 23 stories in 3 months /




Related Stories

Small study reports 100% one‑year survival after lung transplant / 7 wks

High‑dose targeted radiation shows promise for huge bile duct tumors / 4 months

ASTRO issues 2026 radiation guideline update for pancreatic cancer / 14 days

Short‑term fasting may boost chemotherapy response in ovarian cancer / 2 months

Implanted tile radiotherapy reduces brain metastasis recurrence / 2 months

Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 3 months

ESMO issues new metastatic colorectal cancer clinical guideline / 4 months

StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Food Safety, Healthcare, Mergers and Acquisitions, Infectious Disease and look for the RSS link.




↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.